Recalls / Active ingredient / Lidocaine

Lidocaine

8 FDA drug recalls involving the active ingredient “Lidocaine”.

Date	Class	Product	Firm
2024-10-24	Class II	THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5)	Unexo Life Sciences Private Limited
2024-10-24	Class II	EQUATE MAXIMUM STRENGTH LIDOCAINE PAIN RELIEVING PATCH Lidocaine 4% Topical Anesthetic, 6 patches per box PATC	Unexo Life Sciences Private Limited
2023-04-20	Class III	Lidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton (63629-8755-1), Rx only, e	Bryant Ranch Prepack, Inc.
2022-04-13	Class II	Lidocaine and Prilocaine Cream, 2.5%/2.5%, 5 gram tubes, Rx only, MFG: Sandoz Pharma, NDC 0168-0357-56	Mckesson Medical-Surgical Inc. Corporate Office
2022-04-13	Class II	Lidocaine Patch 5%, 30-count carton, Rx only, MFG: Qualitest Products, NDC 0603-1880-16	Mckesson Medical-Surgical Inc. Corporate Office
2022-04-13	Class II	Lidocaine Patch 5%, 30-count box, Rx only, MFG: Teva Pharma USA, NDC 0591-3525-30	Mckesson Medical-Surgical Inc. Corporate Office
2020-07-14	Class II	Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Sal	Teva Pharmaceuticals USA
2018-04-30	Class III	Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC	Teva Pharmaceuticals USA